Proteomic evaluation of biological nanoparticles isolated from human kidney stones and calcified arteries

Farooq A. Shiekh, Jon E. Charlesworth, Sung Hoon Kim, Larry W. Hunter, Muthuvel Jayachandran, Virginia M Miller, John C Lieske

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Calcifying biological nanoparticles (NPs) develop under cell culture conditions from homogenates of diverse tissue samples displaying extraosseous mineralization, including kidney stones and calcified aneurysms. Probes to definitively identify NPs in biological systems are lacking. Therefore, the aim of this study was to begin to establish a proteomic biosignature of NPs in order to facilitate more definitive investigation of their contribution to disease. Biological NPs derived from human kidney stones and calcified aneurysms were completely decalcified by overnight treatment with ethylenediaminetetraacetic acid or brief incubation in HCl, as evidenced by lack of a calcium shell and of Alizarin Red S staining, by transmission electron microscopy and confocal microscopy, respectively. Decalcified NPs contained numerous proteins, including some from bovine serum and others of prokaryotic origin. Most prominent of the latter group was EF-Tu, which appeared to be identical to EF-Tu from Staphylococcus epidermidis. A monoclonal antibody against human EF-Tu recognized a protein in Western blots of total NP lysate, as well as in intact NPs by immunofluorescence and immunogold EM. Approximately 8% of NPs were quantitatively recognized by the antibody using flow cytometry. Therefore, we have defined methods to reproducibly decalcify biological NPs, and identified key components of their proteome. These elements, including EF-Tu, can be used as biomarkers to further define the processes that mediate propagation of biological NPs and their contribution to disease.

Original languageEnglish (US)
Pages (from-to)4065-4072
Number of pages8
JournalActa Biomaterialia
Volume6
Issue number10
DOIs
StatePublished - Oct 2010

Fingerprint

Kidney Calculi
Proteomics
Nanoparticles
Arteries
Peptide Elongation Factor Tu
Proteins
Aneurysm
Calcifying Nanoparticles
Alizarin
Staphylococcus epidermidis
Monoclonal antibodies
Proteome
Flow cytometry
Confocal microscopy
Transmission Electron Microscopy
Ethylenediaminetetraacetic acid
Confocal Microscopy
Biomarkers
Edetic Acid
Biological systems

Keywords

  • Calcification
  • Elongation factor Tu
  • Nanoparticles
  • Nephrolithiasis
  • Proteomics

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Biotechnology
  • Biochemistry
  • Molecular Biology

Cite this

Proteomic evaluation of biological nanoparticles isolated from human kidney stones and calcified arteries. / Shiekh, Farooq A.; Charlesworth, Jon E.; Kim, Sung Hoon; Hunter, Larry W.; Jayachandran, Muthuvel; Miller, Virginia M; Lieske, John C.

In: Acta Biomaterialia, Vol. 6, No. 10, 10.2010, p. 4065-4072.

Research output: Contribution to journalArticle

Shiekh, Farooq A. ; Charlesworth, Jon E. ; Kim, Sung Hoon ; Hunter, Larry W. ; Jayachandran, Muthuvel ; Miller, Virginia M ; Lieske, John C. / Proteomic evaluation of biological nanoparticles isolated from human kidney stones and calcified arteries. In: Acta Biomaterialia. 2010 ; Vol. 6, No. 10. pp. 4065-4072.
@article{d30c7dbd4f454c95806139ff6e64cdc1,
title = "Proteomic evaluation of biological nanoparticles isolated from human kidney stones and calcified arteries",
abstract = "Calcifying biological nanoparticles (NPs) develop under cell culture conditions from homogenates of diverse tissue samples displaying extraosseous mineralization, including kidney stones and calcified aneurysms. Probes to definitively identify NPs in biological systems are lacking. Therefore, the aim of this study was to begin to establish a proteomic biosignature of NPs in order to facilitate more definitive investigation of their contribution to disease. Biological NPs derived from human kidney stones and calcified aneurysms were completely decalcified by overnight treatment with ethylenediaminetetraacetic acid or brief incubation in HCl, as evidenced by lack of a calcium shell and of Alizarin Red S staining, by transmission electron microscopy and confocal microscopy, respectively. Decalcified NPs contained numerous proteins, including some from bovine serum and others of prokaryotic origin. Most prominent of the latter group was EF-Tu, which appeared to be identical to EF-Tu from Staphylococcus epidermidis. A monoclonal antibody against human EF-Tu recognized a protein in Western blots of total NP lysate, as well as in intact NPs by immunofluorescence and immunogold EM. Approximately 8{\%} of NPs were quantitatively recognized by the antibody using flow cytometry. Therefore, we have defined methods to reproducibly decalcify biological NPs, and identified key components of their proteome. These elements, including EF-Tu, can be used as biomarkers to further define the processes that mediate propagation of biological NPs and their contribution to disease.",
keywords = "Calcification, Elongation factor Tu, Nanoparticles, Nephrolithiasis, Proteomics",
author = "Shiekh, {Farooq A.} and Charlesworth, {Jon E.} and Kim, {Sung Hoon} and Hunter, {Larry W.} and Muthuvel Jayachandran and Miller, {Virginia M} and Lieske, {John C}",
year = "2010",
month = "10",
doi = "10.1016/j.actbio.2010.05.004",
language = "English (US)",
volume = "6",
pages = "4065--4072",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",
number = "10",

}

TY - JOUR

T1 - Proteomic evaluation of biological nanoparticles isolated from human kidney stones and calcified arteries

AU - Shiekh, Farooq A.

AU - Charlesworth, Jon E.

AU - Kim, Sung Hoon

AU - Hunter, Larry W.

AU - Jayachandran, Muthuvel

AU - Miller, Virginia M

AU - Lieske, John C

PY - 2010/10

Y1 - 2010/10

N2 - Calcifying biological nanoparticles (NPs) develop under cell culture conditions from homogenates of diverse tissue samples displaying extraosseous mineralization, including kidney stones and calcified aneurysms. Probes to definitively identify NPs in biological systems are lacking. Therefore, the aim of this study was to begin to establish a proteomic biosignature of NPs in order to facilitate more definitive investigation of their contribution to disease. Biological NPs derived from human kidney stones and calcified aneurysms were completely decalcified by overnight treatment with ethylenediaminetetraacetic acid or brief incubation in HCl, as evidenced by lack of a calcium shell and of Alizarin Red S staining, by transmission electron microscopy and confocal microscopy, respectively. Decalcified NPs contained numerous proteins, including some from bovine serum and others of prokaryotic origin. Most prominent of the latter group was EF-Tu, which appeared to be identical to EF-Tu from Staphylococcus epidermidis. A monoclonal antibody against human EF-Tu recognized a protein in Western blots of total NP lysate, as well as in intact NPs by immunofluorescence and immunogold EM. Approximately 8% of NPs were quantitatively recognized by the antibody using flow cytometry. Therefore, we have defined methods to reproducibly decalcify biological NPs, and identified key components of their proteome. These elements, including EF-Tu, can be used as biomarkers to further define the processes that mediate propagation of biological NPs and their contribution to disease.

AB - Calcifying biological nanoparticles (NPs) develop under cell culture conditions from homogenates of diverse tissue samples displaying extraosseous mineralization, including kidney stones and calcified aneurysms. Probes to definitively identify NPs in biological systems are lacking. Therefore, the aim of this study was to begin to establish a proteomic biosignature of NPs in order to facilitate more definitive investigation of their contribution to disease. Biological NPs derived from human kidney stones and calcified aneurysms were completely decalcified by overnight treatment with ethylenediaminetetraacetic acid or brief incubation in HCl, as evidenced by lack of a calcium shell and of Alizarin Red S staining, by transmission electron microscopy and confocal microscopy, respectively. Decalcified NPs contained numerous proteins, including some from bovine serum and others of prokaryotic origin. Most prominent of the latter group was EF-Tu, which appeared to be identical to EF-Tu from Staphylococcus epidermidis. A monoclonal antibody against human EF-Tu recognized a protein in Western blots of total NP lysate, as well as in intact NPs by immunofluorescence and immunogold EM. Approximately 8% of NPs were quantitatively recognized by the antibody using flow cytometry. Therefore, we have defined methods to reproducibly decalcify biological NPs, and identified key components of their proteome. These elements, including EF-Tu, can be used as biomarkers to further define the processes that mediate propagation of biological NPs and their contribution to disease.

KW - Calcification

KW - Elongation factor Tu

KW - Nanoparticles

KW - Nephrolithiasis

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=77956158214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956158214&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2010.05.004

DO - 10.1016/j.actbio.2010.05.004

M3 - Article

C2 - 20466084

AN - SCOPUS:77956158214

VL - 6

SP - 4065

EP - 4072

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

IS - 10

ER -